ID | 68980 |
FullText URL |
suppl1.docx
23.3 KB
suppl2.docx
31.6 KB
|
Author |
Harada, Ko
Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai
Vu, Quynh Thi
Department of Health Data Science, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Nishimura, Yoshito
Division of Hematology/Oncology, Mayo Clinic
Takeda, Tatsuaki
Department of Education and Research Centre for Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Okayama University
Hamano, Hirofumi
Department of Pharmacy, Okayama University Hospital
Minato, Yusuke
Center for Infectious Disease Research, Fujita Health University
Zamami, Yoshito
Department of Pharmacy, Okayama University Hospital
ORCID
Kaken ID
publons
researchmap
Koyama, Toshihiro
Department of Health Data Science, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
ORCID
Kaken ID
publons
researchmap
Hagiya, Hideharu
Department of Infectious Diseases, Okayama University Hospital
ORCID
Kaken ID
researchmap
|
Abstract | Objectives: To examine the international trends for nontuberculous mycobacterial-associated mortality rates, as nontuberculous mycobacterial infections are becoming increasingly prevalent and pose a significant public health challenge, especially in older populations.
Methods: This retrospective observational study used data from the World Health Organization mortality database, which included patients with nontuberculous mycobacterial infection in 83 countries. We stratified the data by sex, age, and geographic region and calculated crude and age-standardized mortality rates to estimate long-term mortality trends. Results: In total, 42,182 nontuberculous mycobacterial infection-associated deaths (58.1% in women) were reported in 83 countries between 2000 and 2022. The locally weighted regression model estimation for the nontuberculous mycobacterial infection-associated mortality rate more than doubled—from 0.36 deaths per 1000,000 individuals in 2000 to 0.77 deaths per 1000,000 individuals in 2022. Eighty-six percent of nontuberculous mycobacterial infection-associated deaths occurred in people aged ≥65 years. The mortality rate was the highest in the Western Pacific Region. Conclusion: This study highlights the impact of emerging nontuberculous mycobacterial diseases and the importance of targeted interventions for managing and reducing mortality, particularly in vulnerable older populations. Further studies are warranted to determine the factors contributing to geographical disparity and treatment options. |
Keywords | Population surveillance
Mortality
Nontuberculous mycobacterial infections
|
Published Date | 2025-09
|
Publication Title |
International Journal of Infectious Diseases
|
Volume | volume158
|
Publisher | Elsevier BV
|
Start Page | 107932
|
ISSN | 1201-9712
|
Content Type |
Journal Article
|
language |
English
|
OAI-PMH Set |
岡山大学
|
Copyright Holders | © 2025 The Authors.
|
File Version | publisher
|
PubMed ID | |
DOI | |
Web of Science KeyUT | |
Related Url | isVersionOf https://doi.org/10.1016/j.ijid.2025.107932
|
License | http://creativecommons.org/licenses/by/4.0/
|
助成情報 |
22K10415:
医療データサイエンスによる高齢者医療の疾病構造に関する臨床疫学研究
( 独立行政法人日本学術振興会 / Japan Society for the Promotion of Science )
( 公益財団法人大山健康財団 / Ohyama Health Foundation Inc. )
|